Optical coherence tomography imaging device comparison study in papilloedema secondary to idiopathic intracranial hypertension - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Study of Optical Coherence Tomography Devices in Assessing Papilloedema Associated with Idiopathic Intracranial Hypertension

  • By

  • Gabriele Berman

  • Andreas Yiangou

  • Mark Thaller

  • Nick Capewell

  • Donna Holding

  • Georgios Tsermoulas

  • Alexandra J. Sinclair

  • Richard J. Blanch

  • Susan P. Mollan

  • September 22, 2026

Share

  • 1

    Optical Coherence Tomography (OCT) is crucial in managing idiopathic intracranial hypertension (IIH) and assessing papilloedema.

  • 2

    The study compares agreement between Heidelberg Spectralis and Zeiss Cirrus 6000 OCT devices in measuring RNFL thickness and other parameters.

  • 3

    Participants included adults with a definite IIH diagnosis, confirmed by elevated lumbar puncture opening pressure and neuroimaging.

  • 4

    Data collection occurred during routine clinical appointments, recording variables like age, sex, and disease duration.

  • 5

    Both OCT devices were used on the same day to ensure comparability in measurements of RNFL thickness and optic nerve parameters.

Original Source(s)

Optical coherence tomography imaging device comparison study in papilloedema secondary to idiopathic intracranial hypertension

  • by Gabriele Berman, Andreas Yiangou, Mark Thaller, Nick Capewell, Donna Holding, Georgios Tsermoulas, Alexandra J. Sinclair, Richard J. Blanch, Susan P. Mollan

  • September 22, 2026

Related Content

HOTV may improve vision screening before age 8

Preschool screening with HOTV yielded fewer referrals and better screening performance than tumbling E, with differences diminishing with age.

Repeat surgical interventions in non-Fuchs corneal dystrophies: insights from eight decades of histopathological and clinical data

Sympathetic ophthalmia complicating proliferative diabetic retinopathy: diagnostic and therapeutic challenges during pregnancy